Rockwell Medical, Inc. (RMTI) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Before we begin, I would like to remind you that this conference call will contain forward-looking statements about Rockwell Medical within the meaning of the federal securities laws, including but not limited to the types of statements identified as forward-looking in our annual report on Form 10-K and our subsequent periodic reports filed with the SEC. These statements are subject to risks and uncertainties that could cause actual results to differ. Please note that these forward-looking statements reflect our opinions and expectations only as of today. Except as required by law, we specifically disclaim any obligation to update or revise these forward-looking statements in light of new information or future events. Factors that could cause actual results or outcomes to differ materially from those expressed in or implied by such forward-looking statements are discussed in greater detail in our periodic reports files at the FCC. Rockwell Medical's quarterly report on Form 10-Q for the three months ended June 30, 2023 was filed prior to this call and provides a full analysis of the company's business strategy as well as the company's second quarter 2023 results. Our Form 10-Q and other reports filed with the SEC along with today's press release and a replay of today's conference call and webcast can be found on Rockwell Medical's website under the Investors section. Now, I would like to turn the conference call over to Rockwell Medical's President and CEO, Dr. Mark Strobeck. Thank you, Heather. Good morning, and thank you for joining us today for Rockwell Medical's second quarter 2023 results conference call and webcast. To get started, I'd like to spend some time reviewing our business strategy and capital structure, including greater detail about our recent acquis...